HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
David S Salomon Selected Research
David S Salomon Research Topics
Disease
36
Neoplasms (Cancer)
10/2023 - 03/2002
11
Breast Neoplasms (Breast Cancer)
10/2023 - 01/2004
11
Carcinoma (Carcinomatosis)
01/2016 - 11/2002
7
Carcinogenesis
04/2016 - 03/2002
4
Triple Negative Breast Neoplasms
01/2020 - 05/2015
4
Colonic Neoplasms (Colon Cancer)
01/2013 - 09/2006
3
Lewis Lung Carcinoma
10/2018 - 01/2012
2
Pancreatic Neoplasms (Pancreatic Cancer)
06/2023 - 12/2020
2
Neoplasm Metastasis (Metastasis)
01/2020 - 06/2010
2
Ovarian Neoplasms (Ovarian Cancer)
07/2008 - 11/2002
2
Endometriosis
09/2007 - 04/2005
1
Tics (Tic)
04/2016
1
Embryonal Carcinoma
01/2016
1
Adenocarcinoma
05/2015
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2014
1
Lung Neoplasms (Lung Cancer)
01/2014
1
Inflammation (Inflammations)
06/2013
1
Teratoma (Teratoid Tumor)
01/2013
1
Hypoxia (Hypoxemia)
11/2009
1
Melanoma (Melanoma, Malignant)
07/2008
1
Pain (Aches)
09/2007
Drug/Important Bio-Agent (IBA)
17
Proteins (Proteins, Gene)
FDA Link
10/2023 - 01/2004
15
Epidermal Growth Factor (EGF)
IBA
01/2022 - 03/2002
8
Conditioned Culture Media
IBA
10/2023 - 10/2007
6
Peptides (Polypeptides)
IBA
01/2013 - 11/2002
4
Messenger RNA (mRNA)
IBA
05/2015 - 10/2004
4
Ligands
IBA
01/2013 - 01/2006
4
Transforming Growth Factor beta (TGF-beta)
IBA
09/2008 - 11/2005
3
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
09/2021 - 03/2002
3
Transcription Factors (Transcription Factor)
IBA
04/2016 - 11/2004
3
Phosphotransferases (Kinase)
IBA
01/2013 - 11/2004
3
Membrane Proteins (Integral Membrane Proteins)
IBA
02/2009 - 02/2008
3
beta Catenin
IBA
09/2008 - 11/2004
2
Epithelial Cell Adhesion Molecule
IBA
10/2023 - 06/2023
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
06/2023 - 01/2004
2
Antibodies
IBA
12/2020 - 07/2008
2
Catenins
IBA
04/2016 - 01/2013
2
Tyrosine Kinase Inhibitors
IBA
07/2014 - 07/2008
2
Trastuzumab (Herceptin)
FDA Link
01/2014 - 01/2013
2
Caveolin 1
IBA
01/2013 - 02/2008
2
Cadherins (E-Cadherin)
IBA
06/2012 - 11/2004
2
Vimentin
IBA
06/2012 - 11/2004
2
Glycoproteins (Glycoprotein)
IBA
08/2010 - 09/2006
2
Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)
IBA
08/2010 - 09/2006
2
ErbB Receptors (EGF Receptor)
IBA
07/2008 - 01/2006
2
Transforming Growth Factor alpha (TGF-alpha)
IBA
10/2004 - 11/2002
1
Prolactin Receptors (Prolactin Receptor)
IBA
10/2023
1
Keratin-8 (Keratin 8)
IBA
10/2023
1
Progesterone Receptors (Progesterone Receptor)
IBA
10/2023
1
Chir 99021
IBA
06/2023
1
AZD 6244
IBA
06/2023
1
oncofetal antigens
IBA
09/2021
1
Carcinogens
IBA
09/2021
1
Antigens
IBA
05/2021
1
Immune Checkpoint Inhibitors
IBA
05/2021
1
Tissue Inhibitor of Metalloproteinase-2
IBA
01/2020
1
RNA (Ribonucleic Acid)
IBA
01/2020
1
sulforaphane
IBA
01/2019
1
Aldehyde Dehydrogenase
IBA
01/2019
1
Docetaxel (Taxotere)
FDA Link
01/2016
1
Glutathione (Reduced Glutathione)
IBA
01/2016
1
Hydrogen Peroxide (Hydroperoxide)
FDA Link
Generic
01/2016
1
MicroRNAs (MicroRNA)
IBA
05/2015
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
07/2014
1
Gefitinib (Iressa)
FDA Link
07/2014
1
Liposomes (Liposome)
IBA
01/2014
1
Hormones (Hormone)
IBA
06/2013
1
Cytoplasmic and Nuclear Receptors (Nuclear Receptors)
IBA
06/2013
1
Member 1 Group A Nuclear Receptor Subfamily 6
IBA
06/2013
1
Apelin
IBA
06/2013
1
Histone Deacetylase Inhibitors
IBA
06/2013
1
DNA (Deoxyribonucleic Acid)
IBA
06/2013
1
SC1 compound
IBA
01/2013
1
Phenobarbital (Luminal)
FDA Link
01/2013
1
Steroid Receptors (Steroid Receptor)
IBA
01/2013
1
Agar
IBA
01/2013
1
GTP Phosphohydrolases (GTPases)
IBA
01/2013
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2013
1
TCF Transcription Factors
IBA
01/2013
1
Eosinophil Cationic Protein
IBA
10/2012
1
Suspensions
IBA
01/2012
1
Blocking Antibodies
IBA
07/2010
1
tyrosine receptor (receptor, tyrosine)
IBA
06/2010
1
Oxygen (Dioxygen)
IBA
11/2009
1
Vaccines
IBA
02/2009
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
04/2008
1
Luciferases
IBA
04/2008
1
Mitogen-Activated Protein Kinases
IBA
02/2008
1
lysophosphatidic acid
IBA
10/2007
1
Chemotactic Factors
IBA
10/2007
1
von Willebrand Factor
IBA
09/2007
1
Substance P
IBA
09/2007
1
GAP-43 Protein (GAP 43 Protein)
IBA
09/2007
1
Nerve Growth Factor (NGF)
IBA
09/2007
Therapy/Procedure
9
Therapeutics
06/2023 - 07/2008
2
Lasers (Laser)
01/2016 - 05/2015
1
Immunotherapy
05/2021
1
Intraperitoneal Injections
01/2019
1
Injections
05/2013
1
Aftercare (After-Treatment)
10/2007